Program Director, Translational Imaging, Center for Health Sciences
Natalie M. Zahr, Ph.D. uses translational in vivo, neuroimaging [magnetic resonance imaging (MRI)] approaches to study the effects of alcohol, HIV, and related comorbidities and rodent models of alcohol use disorder and common concomitants with the goal of identifying peripheral mechanisms that contribute to central nervous system changes in the context of aging.
Dr. Zahr’s training as a basic scientist included teaching gross anatomy and conducting electrophysiology experiments. She completed an M.S. in neuropharmacology from Northeastern University and a Ph.D. in anatomy and neurobiology from Boston University.
For her postdoctoral training, she joined Stanford University as an MRI scientist and over the next several years taught at local institutions including UC Berkeley Extension and Santa Clara University.
Her appointment at SRI International as Program Director of Translational Imaging began in 2016. In 2020, she was appointed Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine (https://profiles.stanford.edu/natalie-zahr).
